BioBlog

Tufts Health Plan and Harvard Pilgrim announced a planned merger, which would make the new as-yet-to-be-named organization a rising competitor to the Partners Health Group, a dominant player in the area. CMS will display the 5-star rating next to plans on the Affordable Care website, a move to make

In this week’s Innovation Partners BioBlog, all eyes are on the pharmaceutical industry. The new Medicare coverage rules for CAR-T therapy may pave the way for adoption of more slow-growing meds. The FDA weighs criminal and civil charges against a subsidiary of Novartis for falsely reporting data.

In this week’s Innovation Partners BioBlog, we look at the many changes and updates in the pharmaceutical world. The Senate’s drug pricing provision is raising alarms for some doctors. Canadian hospitals face a shortage of critical chemotherapy drugs. Eli Lilly’s CEO pushed back at Democratic party

This week in the Innovation Partners BioBlog, Pfizer and Mylan are rumored to be closing a deal that would merge Upjohn with Myland to focus on low-priced drugs. Merck takes another step on the road to immunotherapy treatment for breast cancer. The Trump administration continues its quest for

Democrat Nancy Pelosi announced that the proposed bill from the Democrats to lower drug prices is ready but won’t be unveiled until September. Anthem plans to launch a new health app with a trial rollout in Indiana before national rollout. UnitedHealth published a study examining the costs of

This week’s Innovation Partners BioBlog focuses on the top stories from the oncology sector. GSK announced trial results in its promising ovarian cancer drug, while AbbieVie scooped up Mavpharma to enhance its early stage oncology pipeline. The Trump Administration shot down the drug rebate rule,

Drugmakers breathed a sigh of relief when the courts decided against the HHS rule that television ads would be required to include the price of a 30-day supply of the advertised drug. President Trump indicated he would make a move to help the USA pay similar prices to other nations for drug

In this week’s Innovation Partners BioBlog, we look at several top stories from around the world. New evidence shows that the Affordable Care Act improved cardiac patients’ access thanks to Medicaid expansion. Three states plan to import drugs from Canada where costs for prescription medicines are